Centrum Okulistyczne Eyemed sp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-12-02
Share capital
5,000.00 PLN
Registered address
ul. Dra Witolda Chodźki 10A/401, 20-093 Lublin, Poland
Electronic delivery address
AE:PL-90534-95789-IJHJH-36

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

From the notes

Current income tax (CIT due)$39,163

Filing timeliness

1 of 2 financial statements was filed late (for 2024, 5 days late).

  • 2025filed
  • 202420/07/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Hospital activities245 / 615
Top 40%
Division · Human health activities382 / 6,271
Top 6.1%
City · Lublin264 / 4,827
Top 5.5%
Voivodeship · Lubelskie722 / 10,168
Top 7.1%
Country · Poland24,170 / 297,069
Top 8.1%

Results vs industry

Revenue
This companyUSD 7.54mMedianUSD 3.28mAverageUSD 13.52m
Net profit
This companyUSD 1.20mMedianUSD 60.77kAverageUSD 252.46k
Operating costs
This companyUSD 6.21mMedianUSD 2.99mAverageUSD 12.86m
Assets
This companyUSD 4.41mMedianUSD 2.21mAverageUSD 10.96m

Public procurement

1 tender recorded as contractor, with a total value of $296,499.

SubjectAmount
Call for tenders for inpatient treatment – drug programmes
$296.5K

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2011. In 2026 it is performing 5 contracts with a total value of USD 4.51m. All its contracts were worth USD 31.63m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentlubelskie3USD 3.34m
Outpatient specialist carelubelskie2USD 1.17m

NFZ waiting lists

This company's facilities run 8 NFZ waiting lists. Waiting time forecast by NFZ, as of 10.11.2026.

ServiceWaiting time
Day treatment ward3 days
Treatment of patients with retinal diseases (AMD, DME)5 days
Lens procedures (cataract)1 mo 2 wk
Vitreous procedures (vitrectomy)2 mo 3 wk
Ophthalmology services4 mo 3 wk

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2025.

MarkNumberClassesStatusProtected until
EYEMED Z.58364444Application pending –
EYEMED Z.58364744Application pending –
MarkProtected until
EYEMED –
EYEMED –

Authorized Representatives

Iwona Szymaniak-Rokita age 58 – Management Board Member
Sławomir Rokita age 57 – President of the Management Board

Manner of representation

Each member of the management board independently is authorised to make declarations of will on behalf of the company and to represent it, both in the case of a one-person management board and in the case of a multi-member management board.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

Iwona Szymaniak Rokita and Sławomir Rokita hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-11-02.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$44,569
Buildings and premises
$2.2M

Public aid

9 public aid cases recorded, with a total value of $1,220,030.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$172K
Regional investment aid
$164.9K
Regional investment aid
$96,359

Regulatory authorisations

AuthorityTypeStatus
Consumer credit intermediary Active
BDO register entry Active

FAQ

Last updated: 2026-04-15